Imunexus
Business Services · Australia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Building, 2 Science Dr Lims, Bundoora, V...Phone Number
+61 396627100Website
www.imunexus.comRevenue
<$5 MillionIndustry
About Imunexus
Imunexus Therapeutics is an Australian biotechnology company focused on developing next-generation biologic medicines for serious diseases, particularly multiple sclerosis. Utilizing their proprietary imunexin technology platform, they create multispecific biologics that target multiple biological pathways within a single therapy. Their lead program, IMX39, aims to modify disease progression in multiple sclerosis while supporting nerve repair mechanisms. The company also has a growing pipeline addressing various conditions, including oncology and rare diseases.Explore more
Imunexus Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Imunexus
Compare insights from companies similar to Imunexus, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Imunexus Tech Stack
A closer look at the technologies used by Imunexus
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Imunexus
Sign Up For FreeTo access detailed company insights
Imunexus Therapeutics is an Australian biotechnology company focused on developing next-generation biologic medicines for serious diseases, particularly multiple sclerosis. Utilizing their proprietary imunexin technology platform, they create multispecific biologics that target multiple biological pathways within a single therapy. Their lead progra... Read More
